Are there sex disparities in the treatment and control of cardiovascular risk factors between women and men with type 2 diabetes and CVD?
This study highlights significant sex disparities in secondary prevention for patients with type 2 diabetes, with women receiving less intensive lipid-lowering therapy and achieving poorer risk factor control.
Women with diabetes and CVD have poorer control of important modifiable risk factors than men and receive less intensified lipid-lowering treatment.
Gouni‐Berthold et al. (Sat,) studied this question.